Search results
Innovent to take IL-23 psoriasis drug to Chinese regulators after phase 3 win
FierceBiotech· 1 hour agoThe anti-IL-23 monoclonal antibody, called picankibart, hit all primary and key secondary endpoints...
Innovent’s psoriasis treatment picankibart meets all endpoints in Phase III trial
Clinical Trials Arena via Yahoo Finance· 4 hours ago“We will actively prepare to submit the new drug application of picankibart based on the CLEAR-1...
...Phase 3 Clinical Trial in Treating Moderate to Severe Plaque Psoriasis, and Plans to Submit NDA...
KTLA-TV Los Angeles· 13 hours agoCLEAR-1 is global the first Phase 3 registration study in IL-23p19 class that reported over 80% of subjects...
Home Phototherapy for Psoriasis: Optimizing Access
Medscape· 6 days agoSupporters of home phototherapy for patients with plaque and guttate psoriasis had plenty to cheer about at the annual meeting of the American Academy of...
Finding the Best Psoriasis Treatment: How I Got Psoriasis Relief
Verywell Health via Yahoo News· 7 days agoWith two kids under 2, I needed some relief. I had been through enough psoriasis treatment and had...
Zai Lab doses first subject in Phase II plaque psoriasis treatment trial
Clinical Trials Arena via Yahoo Finance· 5 days ago"Zai Lab doses first subject in Phase II plaque psoriasis treatment trial" was originally created...
7 Biotech Stocks to Put on Your Breakthrough Radar
InvestorPlace· 20 hours agoFor those seeking to decipher best speculative opportunities in the market, biotech stocks with breakthrough potential may offer plenty of firepower....
AbbVie (NYSE:ABBV) vs. Cosmo Pharmaceuticals (OTC:CMOPF) Head to Head Review
ETF DAILY NEWS· 3 days agoAbbVie (NYSE:ABBV – Get Free Report) and Cosmo Pharmaceuticals (OTC:CMOPF – Get Free Report) are both medical companies, but which is the better investment? We will compare the two businesses ...
Maintenance Tx With Guselkumab for UC Meets All Endpoints
Medscape· 6 days agoGuselkumab (Tremfya, Janssen/Johnson & Johnson) was superior to placebo for maintenance therapy in...
Guselkumab Continues Winning Streak in Crohn's Disease
MedPage Today· 6 days agoInduction and maintenance treatment with guselkumab (Tremfya) demonstrated its safety and efficacy...